SlideShare a Scribd company logo
Microbiota & Diabetes
Abdulmoein Eid Al-Agha, FRCPCH
Professor of Pediatric Endocrinology, Head,
Pediatric Endocrinology & Diabetes section,
King Abdulaziz University Hospital, Saudi Arabia
www.aagha.kau.edu.sa
Objectives
• Introduction into human microbiota (what are they?)
• What do we know on Gut microbiota?
• Environmental factors affecting Gut microbiota (from antenatal life till adulthood)
• Dysbiosis of the microbiota (change beneficial bacteria to abnormal dysregulated
ones)
• High fat diet associated & obesity leads to microbiota dysbiosis which leads to type 2
DM & Metabolic syndrome
• Dysbiotic microbiota associations with various diseases including:
• Obesity, insulin resistance, type 2 DM & type 1 DM
What is the “Microbiota”?
“the ecological community of commensal,
symbiotic, & pathogenic microorganisms that share
our body space”
• gene sequencing on samples from 5 female body sites
(gastrointestinal, mouth, vagina, skin, and nasal cavity) and 4
male body sites
Bacterial Distribution by body site
(Peterson, et al. 2009)
Symbiotic & Dysbiotic Microbiota
•What do we know about the gut
Microbiota in health/ Disease states?
Gut Microbiota
Gut Microbiota
• Trillions of micro-organisms inhabit the distal gut, where they
together weigh about 1.5 kg
• Regarded as a microbial organ that carries out key functions
that the human host is incapable to perform by itself
• More than 90% of the prevalent bacterial species can be
grouped into the two bacterial Phyla Firmicutes (Gram-
positive) & Bacteroidetes (Gram-negative)
Composition & luminal concentrations of dominant microbial species
in various regions of the gastrointestinal tract
Gastroenterology 2008 134(2)
Beneficial Effects of Gut Microbiota
• Protects against pathogens
• Helps maturate and constantly educate the immune system
• Plays a role for regulation of intestinal hormone secretions & for
gastrointestinal nerve activity
• Members of gut microbiota synthesize vitamin K , folate & vitamin
B12
• Produce short-chain fatty acids (SCFAs) by fermentation of
otherwise non-digestible carbohydrates
Factors affecting Gut Microbiome
Breast -vs- formula
Breast Fed Formula Fed
Bifidobacteria Bifidobacteria
Enterobacteria Escherichia Coli
Clostridium difficle
Bacteriodes
Prevotella
Lactobacillus
Enterobacteriaceae
The gut Microbiota during the human lifespan
“Dysbiosis”= dysregulated (abnormal)
Microbiota
“Father of Medicine”
Hippocrates 'famous statement that “all disease
begins in the gut” recognized the essential role
played by the gut & diet in many of the vital
homoeostatic functions of the human body
Metabolic diseases
IBD Obesity& Type 2 DM
CDI Malignancy
Celiac disease Type I DM
Allergies NASH
Autism Depression
Alterations in gut Microbiota have been
linked with:
Impact of diet on gut Microbiota
• A healthy gut microbiome is characterized by the presence of
microbes that enhance metabolism, & are resilient to infection and
inflammation and resistant to autoimmunity and cancer
• Studies examining the influence of nutrients (such as dietary fibers
and fats) and dietary habits (vegetarians or vegans) in different
populations have allowed stratification of the human population
based on three principal bacteria and their micro biome's genetic
abundance
Gut Microbiota dysbiosis & Type 2 DM
Risk factors for type 2 diabetes, including:
• Genetic predisposition
• Poor physical activity
• Fetal programming
• Obesity
• Altered configuration of the Microbiota has emerged as a new candidate that
may be linked to obesity & type 2 diabetes
Microbiota Dysbiosis associated with Type 2
Diabetes
• Alterations in the gut microbiota have been linked to the increasing
prevalence of metabolic disorders including obesity, insulin resistance &
type 2 diabetes
• Accumulating evidence over the past decade has linked the development of
metabolic syndrome related to diabetes to variations in gut microbiota
• Remarkably, decreased synthesis of short-chain fatty acids, have been
significantly associated with the predisposition to diabetes and related
disorders
High Fat Diet & Gut Microbiota dysbiosis
Metabolic Endotoxemia Phenomenon
• High-fat diet (HFD) is known to translocate
microbiota into a lipopolysaccharide (LPS)-enriched
intestinal microbiota with a consequently elevated
plasma concentration of LPS, which characterizes a
state of metabolic Endotoxemia
• Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N, et al. Changes in gut
microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced
obesity and diabetes in mice. Diabetes (2008) 57:1470–81.10.2337/db07-1403
High Fiber diet will increase proportion and
function of gut Microbiota
Pre/Probiotics as for healthy intestinal
microbiota
High Fat Diet & Type 2 Diabetes
• HFD has also been shown to cause a loss of intestinal T helper (Th) 17 cells putatively
through an altered gut microbiota that interfere with the induction of Th17 cells by the
antigen-presenting cells, resulting in diminished intestinal defense and integrity
• Moreover, it has been demonstrated that immunization with the HFD-associated ileum
microbial extracts reversed partially gut microbiota Dysbiosis and prevented
hyperglycemia and insulin resistance in response to HFD likely by enhancing the
proliferation of intestinal CD4 T cells
• This underlines the potential of vaccination for preventing and managing T2DM
Conclusion “Dysbiosis of gut Microbiota &
obesity with type 2 DM”
• As the dysbiosis of gut microbiota is increasingly
appreciated as a mechanism accounting for metabolic
diseases, the growing understanding of microbiota-
driven immune and metabolic responses has begun to
reveal potential interventional targets, sustaining the
development of new therapeutic strategies by dietary
and/or pharmacological means
Conclusion “Dysbiosis of gut Microbiota &
obesity with type 2 DM”
• Dietary intervention (e.g., prebiotics, probiotics, and postbiotics)
and fecal microbiota transplantation that tackle microbiota
Dysbiosis
• Manipulation of the key players in the intestinal integrity and
function, bacterial recognition and translocation, tissue
inflammation, and host nutrient-sensing mechanisms by using :
• recent reports about vaccination and genetic modulation of the gut
microbial metabolites further add to our knowledge of the therapeutics of
metabolic diseases
The “Perfect Storm” for Type 1 Diabetes
The Complex Interplay Between Intestinal
Microbiota, Gut Permeability, and Mucosal
Immunity
Dysbiosis of gut Microbiota & type 1 diabetes
• Recent data showed the critical role of the gastrointestinal microbiota in the
protection or the triggering of type 1 diabetes
• In both models, the target pancreatic insulin producing beta cells are attacked
and destroyed by activated immune cells, leading to type-1 diabetes.
• In human, the incidence of type 1 diabetes has increased during the
past several decades in developed countries where environmental
conditions have dramatically changed
Dysbiosis of gut Microbiota & type 1 diabetes
• Increased intestinal permeability has been observed in
animal models of type 1 diabetes as well as in humans with
or at increased-risk for the disease
• An altered mucosal immune system has been associated with
the disease and is likely a major contributor resulting in the
autoimmunity that underlies type 1 diabetes
Dysbiosis of gut Microbiota & type 1
diabetes
• This hypothesis suggests that bacterial antigens would be presented by the innate immune
system to the T lymphocytes very early in life supporting the notion that immunostimulation
can benefit the maturation of the postnatal immune system
• Consequently, in case of misrecognition of the bacterial antigen, the adaptive immune system
will be exacerbating its aggressiveness against the pancreatic cells and destroy them
• Consequently, the recognition of bacterial determinants from intestinal Microbiota would be
a triggering factor of autoimmune disease
• The Toll-like receptors (TLRs) are innate pattern-recognition receptors involved in host
defense that control over commensal bacteria and maintain tissue integrity
• The corresponding signaling molecule is MyD88 adaptor, therefore mice lacking this
molecular mechanisms were protected against insulitis
Hypothetical model of the contribution of various gut components to the pathogenesis of type 1 diabetes.
Outi Vaarala et al. Diabetes 2008;57:2555-2562
©2008 by American Diabetes Association
Conclusion
• Clearly, much work remains in terms of understanding the role of the gut
in type 1 & type 2 diabetes development.
• Despite numerous studies showing health benefits of probiotics, the
enthusiasm for their application as well as other means to alter the
intestinal microbial ecosystem in the prevention of diabetes needs to be
tempered due to the current lack of knowledge of the normal developing
intestinal microbiota, in addition to questions as to how it affects the
developing immune system
Conclusion /Future understanding
• Future studies using newly developed techniques to evaluate
intestinal Microbiota, coupled with the rapidly emerging fields
of proteomics and metabolomics, are certainly needed
• Finally, the role of gut as modulator of –cell autoimmunity,
and/or as the place for initiation of –cell autoimmunity, should
provide new understanding of the changing incidence of type 1
diabetes at different times and in different populations
Thank You

More Related Content

What's hot

Gut microbiota
Gut microbiotaGut microbiota
Gut microbiota
Saurav Das
 
Gut microbiota
Gut microbiotaGut microbiota
Gut microbiota
Akram Najafi
 
GUT MICROBIOMES
GUT MICROBIOMESGUT MICROBIOMES
GUT MICROBIOMES
latha13061996
 
Microbiota Dysbiosis
Microbiota DysbiosisMicrobiota Dysbiosis
Microbiota Dysbiosis
fathi neana
 
Human microbiome in health and disease
Human microbiome in health and diseaseHuman microbiome in health and disease
Human microbiome in health and disease
Shivanshu Bajaj
 
Gut microbiome slideshare
Gut microbiome slideshareGut microbiome slideshare
Gut microbiome slideshare
monaDubey3
 
Microbiome Talk
Microbiome TalkMicrobiome Talk
Microbiome Talk
Robin Ingersoll
 
Gut microbiota in health and disease
Gut microbiota in health and disease  Gut microbiota in health and disease
Gut microbiota in health and disease
Monkez M Yousif
 
Gut microbiome and host health
Gut microbiome and host health  Gut microbiome and host health
Gut microbiome and host health
SANTHANAKUMARV
 
An overview of gut microbiota
An overview of gut microbiota An overview of gut microbiota
An overview of gut microbiota
Asma AlQahtani
 
The leaky gut syndrome
The leaky gut syndromeThe leaky gut syndrome
The leaky gut syndrome
fathi neana
 
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Fabio Piccini
 
Gutbrain cross talk
Gutbrain cross talkGutbrain cross talk
Gutbrain cross talk
Aratrika Sen
 
Human intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseasesHuman intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseases
arnab ghosh
 
microbiome.pptx
microbiome.pptxmicrobiome.pptx
microbiome.pptx
Ritasman Baisya
 
Gut brain axis and microbiota
Gut brain axis and microbiotaGut brain axis and microbiota
Gut brain axis and microbiota
DRMOHITKHER
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity
Erin Davis
 
Microbiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseasesMicrobiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseases
Maurizio Salamone
 
Microvascular complications of diabetes pathophysiology
Microvascular complications of diabetes pathophysiologyMicrovascular complications of diabetes pathophysiology
Microvascular complications of diabetes pathophysiology
MWIZERWA JEAN-LUC
 
nutrigenomics.ppt
nutrigenomics.pptnutrigenomics.ppt
nutrigenomics.ppt
RainaJain22
 

What's hot (20)

Gut microbiota
Gut microbiotaGut microbiota
Gut microbiota
 
Gut microbiota
Gut microbiotaGut microbiota
Gut microbiota
 
GUT MICROBIOMES
GUT MICROBIOMESGUT MICROBIOMES
GUT MICROBIOMES
 
Microbiota Dysbiosis
Microbiota DysbiosisMicrobiota Dysbiosis
Microbiota Dysbiosis
 
Human microbiome in health and disease
Human microbiome in health and diseaseHuman microbiome in health and disease
Human microbiome in health and disease
 
Gut microbiome slideshare
Gut microbiome slideshareGut microbiome slideshare
Gut microbiome slideshare
 
Microbiome Talk
Microbiome TalkMicrobiome Talk
Microbiome Talk
 
Gut microbiota in health and disease
Gut microbiota in health and disease  Gut microbiota in health and disease
Gut microbiota in health and disease
 
Gut microbiome and host health
Gut microbiome and host health  Gut microbiome and host health
Gut microbiome and host health
 
An overview of gut microbiota
An overview of gut microbiota An overview of gut microbiota
An overview of gut microbiota
 
The leaky gut syndrome
The leaky gut syndromeThe leaky gut syndrome
The leaky gut syndrome
 
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
Diet microbiota interactions: the mediterranean diet as a key to a healthy mi...
 
Gutbrain cross talk
Gutbrain cross talkGutbrain cross talk
Gutbrain cross talk
 
Human intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseasesHuman intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseases
 
microbiome.pptx
microbiome.pptxmicrobiome.pptx
microbiome.pptx
 
Gut brain axis and microbiota
Gut brain axis and microbiotaGut brain axis and microbiota
Gut brain axis and microbiota
 
Microbiome and obesity
Microbiome and obesity Microbiome and obesity
Microbiome and obesity
 
Microbiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseasesMicrobiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseases
 
Microvascular complications of diabetes pathophysiology
Microvascular complications of diabetes pathophysiologyMicrovascular complications of diabetes pathophysiology
Microvascular complications of diabetes pathophysiology
 
nutrigenomics.ppt
nutrigenomics.pptnutrigenomics.ppt
nutrigenomics.ppt
 

Similar to Diabetes & microbiota

Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptxDysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
VidushRatan1
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
ueda2015
 
Probiotics and prebiotics
Probiotics and prebioticsProbiotics and prebiotics
Probiotics and prebiotics
Asif nawaz khan (AUST)
 
microbiata.pdf
microbiata.pdfmicrobiata.pdf
microbiata.pdf
mohieeldien elsayed
 
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
Vinod Nikhra
 
Microbiota intestinale e Patologie Neurodegenerative
Microbiota intestinale e Patologie NeurodegenerativeMicrobiota intestinale e Patologie Neurodegenerative
Microbiota intestinale e Patologie Neurodegenerative
ASMaD
 
Neutraceuticals - Probiotics, Prebiotics & Synbiotics
Neutraceuticals - Probiotics, Prebiotics & SynbioticsNeutraceuticals - Probiotics, Prebiotics & Synbiotics
Neutraceuticals - Probiotics, Prebiotics & Synbiotics
Mayur D. Chauhan
 
neutraceuticals-151002080111-lva1-app6892.pdf
neutraceuticals-151002080111-lva1-app6892.pdfneutraceuticals-151002080111-lva1-app6892.pdf
neutraceuticals-151002080111-lva1-app6892.pdf
satbirkaur28
 
Probiotics in health & disease.pdf
Probiotics in health & disease.pdfProbiotics in health & disease.pdf
Probiotics in health & disease.pdf
TwanaOmar4
 
Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological target
Adeel Zafar
 
AAPCE 2019 Westfall - Probiotics.pptx
AAPCE 2019 Westfall - Probiotics.pptxAAPCE 2019 Westfall - Probiotics.pptx
AAPCE 2019 Westfall - Probiotics.pptx
venwen
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.
Shaikhani.
 
"Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?""Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?"
ibdsf00
 
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-DeebPre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
Dalia Deeb
 
Veekshith02
Veekshith02Veekshith02
Veekshith02
VeekshithYeddula
 
Prebiotics and Probiotics
Prebiotics and ProbioticsPrebiotics and Probiotics
Prebiotics and Probiotics
Rinisha Sinha
 
Gut microbiome obesity nafld
Gut microbiome obesity nafldGut microbiome obesity nafld
Gut microbiome obesity nafld
joannayeh
 
Dysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptxDysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptx
Mohamed Wifi
 
Microbiome; the microorganisms naturally present in an individual.pptx
Microbiome; the microorganisms naturally present in an individual.pptxMicrobiome; the microorganisms naturally present in an individual.pptx
Microbiome; the microorganisms naturally present in an individual.pptx
MichaelBoateng40
 
Pre por and pae dr.niteen141014183151-conversion-gate01
Pre por and pae dr.niteen141014183151-conversion-gate01Pre por and pae dr.niteen141014183151-conversion-gate01
Pre por and pae dr.niteen141014183151-conversion-gate01
drnitin120
 

Similar to Diabetes & microbiota (20)

Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptxDysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
Dysbiosis & Probiotics Gyn Final (1) [Autosaved].pptx
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
 
Probiotics and prebiotics
Probiotics and prebioticsProbiotics and prebiotics
Probiotics and prebiotics
 
microbiata.pdf
microbiata.pdfmicrobiata.pdf
microbiata.pdf
 
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
The gut microbial dysbiosis its fallouts and therapeutic potential of gut mic...
 
Microbiota intestinale e Patologie Neurodegenerative
Microbiota intestinale e Patologie NeurodegenerativeMicrobiota intestinale e Patologie Neurodegenerative
Microbiota intestinale e Patologie Neurodegenerative
 
Neutraceuticals - Probiotics, Prebiotics & Synbiotics
Neutraceuticals - Probiotics, Prebiotics & SynbioticsNeutraceuticals - Probiotics, Prebiotics & Synbiotics
Neutraceuticals - Probiotics, Prebiotics & Synbiotics
 
neutraceuticals-151002080111-lva1-app6892.pdf
neutraceuticals-151002080111-lva1-app6892.pdfneutraceuticals-151002080111-lva1-app6892.pdf
neutraceuticals-151002080111-lva1-app6892.pdf
 
Probiotics in health & disease.pdf
Probiotics in health & disease.pdfProbiotics in health & disease.pdf
Probiotics in health & disease.pdf
 
Gut microbiomes as pharmacological target
Gut microbiomes as pharmacological targetGut microbiomes as pharmacological target
Gut microbiomes as pharmacological target
 
AAPCE 2019 Westfall - Probiotics.pptx
AAPCE 2019 Westfall - Probiotics.pptxAAPCE 2019 Westfall - Probiotics.pptx
AAPCE 2019 Westfall - Probiotics.pptx
 
Git j club fmt.
Git j club fmt.Git j club fmt.
Git j club fmt.
 
"Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?""Probiotics: What Are They? What Can They Do for You?"
"Probiotics: What Are They? What Can They Do for You?"
 
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-DeebPre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
Pre and probiotics in colorectal cancer Prevention By Dalia Khamis El-Deeb
 
Veekshith02
Veekshith02Veekshith02
Veekshith02
 
Prebiotics and Probiotics
Prebiotics and ProbioticsPrebiotics and Probiotics
Prebiotics and Probiotics
 
Gut microbiome obesity nafld
Gut microbiome obesity nafldGut microbiome obesity nafld
Gut microbiome obesity nafld
 
Dysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptxDysbiosis and NAFLD.pptx
Dysbiosis and NAFLD.pptx
 
Microbiome; the microorganisms naturally present in an individual.pptx
Microbiome; the microorganisms naturally present in an individual.pptxMicrobiome; the microorganisms naturally present in an individual.pptx
Microbiome; the microorganisms naturally present in an individual.pptx
 
Pre por and pae dr.niteen141014183151-conversion-gate01
Pre por and pae dr.niteen141014183151-conversion-gate01Pre por and pae dr.niteen141014183151-conversion-gate01
Pre por and pae dr.niteen141014183151-conversion-gate01
 

More from Abdulmoein AlAgha

Type 2 DM in children & adolescents management overview
Type 2 DM in children & adolescents management overviewType 2 DM in children & adolescents management overview
Type 2 DM in children & adolescents management overview
Abdulmoein AlAgha
 
Thyroid disorders in children
Thyroid disorders in childrenThyroid disorders in children
Thyroid disorders in children
Abdulmoein AlAgha
 
Growth hormone testing
Growth hormone testingGrowth hormone testing
Growth hormone testing
Abdulmoein AlAgha
 
Metabolic bone disease with focus on hypophosphatasia
Metabolic bone disease with focus on hypophosphatasiaMetabolic bone disease with focus on hypophosphatasia
Metabolic bone disease with focus on hypophosphatasia
Abdulmoein AlAgha
 
The role of nutrition in children growth & health
The role of nutrition in children growth & healthThe role of nutrition in children growth & health
The role of nutrition in children growth & health
Abdulmoein AlAgha
 
Diabetes technology &patient self care
Diabetes technology &patient self careDiabetes technology &patient self care
Diabetes technology &patient self care
Abdulmoein AlAgha
 
Vitamin d deficiency & rickets
Vitamin d deficiency & ricketsVitamin d deficiency & rickets
Vitamin d deficiency & rickets
Abdulmoein AlAgha
 
Pediatric growth hormone deficiency
Pediatric growth hormone deficiencyPediatric growth hormone deficiency
Pediatric growth hormone deficiency
Abdulmoein AlAgha
 
Types of insulin & correction of hyperglycemia
Types of insulin & correction of hyperglycemiaTypes of insulin & correction of hyperglycemia
Types of insulin & correction of hyperglycemia
Abdulmoein AlAgha
 
Vitamin d deficiency in children
Vitamin d deficiency in childrenVitamin d deficiency in children
Vitamin d deficiency in children
Abdulmoein AlAgha
 
Various types of diabetes in children
Various types of diabetes in childrenVarious types of diabetes in children
Various types of diabetes in children
Abdulmoein AlAgha
 
Growth hormone therapy
Growth hormone therapyGrowth hormone therapy
Growth hormone therapy
Abdulmoein AlAgha
 
Fating Ramadan & type 1 diabetes
Fating Ramadan & type 1 diabetesFating Ramadan & type 1 diabetes
Fating Ramadan & type 1 diabetes
Abdulmoein AlAgha
 
Diabetes+ketoacidosis
Diabetes+ketoacidosisDiabetes+ketoacidosis
Diabetes+ketoacidosis
Abdulmoein AlAgha
 
Degludec presentation
Degludec presentation Degludec presentation
Degludec presentation
Abdulmoein AlAgha
 
Delayed puberty in children
Delayed puberty in childrenDelayed puberty in children
Delayed puberty in children
Abdulmoein AlAgha
 
Short stature definition and approach
Short stature definition and approachShort stature definition and approach
Short stature definition and approach
Abdulmoein AlAgha
 
type 1 diabetes in children
type 1 diabetes in childrentype 1 diabetes in children
type 1 diabetes in children
Abdulmoein AlAgha
 
Pediatric endocrinology review MCQs- part 6
Pediatric endocrinology review MCQs- part 6Pediatric endocrinology review MCQs- part 6
Pediatric endocrinology review MCQs- part 6
Abdulmoein AlAgha
 
Safety of GH therapy
Safety of GH therapySafety of GH therapy
Safety of GH therapy
Abdulmoein AlAgha
 

More from Abdulmoein AlAgha (20)

Type 2 DM in children & adolescents management overview
Type 2 DM in children & adolescents management overviewType 2 DM in children & adolescents management overview
Type 2 DM in children & adolescents management overview
 
Thyroid disorders in children
Thyroid disorders in childrenThyroid disorders in children
Thyroid disorders in children
 
Growth hormone testing
Growth hormone testingGrowth hormone testing
Growth hormone testing
 
Metabolic bone disease with focus on hypophosphatasia
Metabolic bone disease with focus on hypophosphatasiaMetabolic bone disease with focus on hypophosphatasia
Metabolic bone disease with focus on hypophosphatasia
 
The role of nutrition in children growth & health
The role of nutrition in children growth & healthThe role of nutrition in children growth & health
The role of nutrition in children growth & health
 
Diabetes technology &patient self care
Diabetes technology &patient self careDiabetes technology &patient self care
Diabetes technology &patient self care
 
Vitamin d deficiency & rickets
Vitamin d deficiency & ricketsVitamin d deficiency & rickets
Vitamin d deficiency & rickets
 
Pediatric growth hormone deficiency
Pediatric growth hormone deficiencyPediatric growth hormone deficiency
Pediatric growth hormone deficiency
 
Types of insulin & correction of hyperglycemia
Types of insulin & correction of hyperglycemiaTypes of insulin & correction of hyperglycemia
Types of insulin & correction of hyperglycemia
 
Vitamin d deficiency in children
Vitamin d deficiency in childrenVitamin d deficiency in children
Vitamin d deficiency in children
 
Various types of diabetes in children
Various types of diabetes in childrenVarious types of diabetes in children
Various types of diabetes in children
 
Growth hormone therapy
Growth hormone therapyGrowth hormone therapy
Growth hormone therapy
 
Fating Ramadan & type 1 diabetes
Fating Ramadan & type 1 diabetesFating Ramadan & type 1 diabetes
Fating Ramadan & type 1 diabetes
 
Diabetes+ketoacidosis
Diabetes+ketoacidosisDiabetes+ketoacidosis
Diabetes+ketoacidosis
 
Degludec presentation
Degludec presentation Degludec presentation
Degludec presentation
 
Delayed puberty in children
Delayed puberty in childrenDelayed puberty in children
Delayed puberty in children
 
Short stature definition and approach
Short stature definition and approachShort stature definition and approach
Short stature definition and approach
 
type 1 diabetes in children
type 1 diabetes in childrentype 1 diabetes in children
type 1 diabetes in children
 
Pediatric endocrinology review MCQs- part 6
Pediatric endocrinology review MCQs- part 6Pediatric endocrinology review MCQs- part 6
Pediatric endocrinology review MCQs- part 6
 
Safety of GH therapy
Safety of GH therapySafety of GH therapy
Safety of GH therapy
 

Recently uploaded

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 

Recently uploaded (20)

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 

Diabetes & microbiota

  • 1. Microbiota & Diabetes Abdulmoein Eid Al-Agha, FRCPCH Professor of Pediatric Endocrinology, Head, Pediatric Endocrinology & Diabetes section, King Abdulaziz University Hospital, Saudi Arabia www.aagha.kau.edu.sa
  • 2. Objectives • Introduction into human microbiota (what are they?) • What do we know on Gut microbiota? • Environmental factors affecting Gut microbiota (from antenatal life till adulthood) • Dysbiosis of the microbiota (change beneficial bacteria to abnormal dysregulated ones) • High fat diet associated & obesity leads to microbiota dysbiosis which leads to type 2 DM & Metabolic syndrome • Dysbiotic microbiota associations with various diseases including: • Obesity, insulin resistance, type 2 DM & type 1 DM
  • 3. What is the “Microbiota”? “the ecological community of commensal, symbiotic, & pathogenic microorganisms that share our body space”
  • 4. • gene sequencing on samples from 5 female body sites (gastrointestinal, mouth, vagina, skin, and nasal cavity) and 4 male body sites Bacterial Distribution by body site (Peterson, et al. 2009)
  • 6.
  • 7. •What do we know about the gut Microbiota in health/ Disease states?
  • 9. Gut Microbiota • Trillions of micro-organisms inhabit the distal gut, where they together weigh about 1.5 kg • Regarded as a microbial organ that carries out key functions that the human host is incapable to perform by itself • More than 90% of the prevalent bacterial species can be grouped into the two bacterial Phyla Firmicutes (Gram- positive) & Bacteroidetes (Gram-negative)
  • 10. Composition & luminal concentrations of dominant microbial species in various regions of the gastrointestinal tract Gastroenterology 2008 134(2)
  • 11. Beneficial Effects of Gut Microbiota • Protects against pathogens • Helps maturate and constantly educate the immune system • Plays a role for regulation of intestinal hormone secretions & for gastrointestinal nerve activity • Members of gut microbiota synthesize vitamin K , folate & vitamin B12 • Produce short-chain fatty acids (SCFAs) by fermentation of otherwise non-digestible carbohydrates
  • 12. Factors affecting Gut Microbiome
  • 13.
  • 14.
  • 15. Breast -vs- formula Breast Fed Formula Fed Bifidobacteria Bifidobacteria Enterobacteria Escherichia Coli Clostridium difficle Bacteriodes Prevotella Lactobacillus Enterobacteriaceae
  • 16. The gut Microbiota during the human lifespan
  • 17.
  • 18.
  • 20. “Father of Medicine” Hippocrates 'famous statement that “all disease begins in the gut” recognized the essential role played by the gut & diet in many of the vital homoeostatic functions of the human body
  • 21.
  • 22. Metabolic diseases IBD Obesity& Type 2 DM CDI Malignancy Celiac disease Type I DM Allergies NASH Autism Depression Alterations in gut Microbiota have been linked with:
  • 23.
  • 24. Impact of diet on gut Microbiota • A healthy gut microbiome is characterized by the presence of microbes that enhance metabolism, & are resilient to infection and inflammation and resistant to autoimmunity and cancer • Studies examining the influence of nutrients (such as dietary fibers and fats) and dietary habits (vegetarians or vegans) in different populations have allowed stratification of the human population based on three principal bacteria and their micro biome's genetic abundance
  • 25. Gut Microbiota dysbiosis & Type 2 DM Risk factors for type 2 diabetes, including: • Genetic predisposition • Poor physical activity • Fetal programming • Obesity • Altered configuration of the Microbiota has emerged as a new candidate that may be linked to obesity & type 2 diabetes
  • 26. Microbiota Dysbiosis associated with Type 2 Diabetes • Alterations in the gut microbiota have been linked to the increasing prevalence of metabolic disorders including obesity, insulin resistance & type 2 diabetes • Accumulating evidence over the past decade has linked the development of metabolic syndrome related to diabetes to variations in gut microbiota • Remarkably, decreased synthesis of short-chain fatty acids, have been significantly associated with the predisposition to diabetes and related disorders
  • 27. High Fat Diet & Gut Microbiota dysbiosis
  • 28.
  • 29. Metabolic Endotoxemia Phenomenon • High-fat diet (HFD) is known to translocate microbiota into a lipopolysaccharide (LPS)-enriched intestinal microbiota with a consequently elevated plasma concentration of LPS, which characterizes a state of metabolic Endotoxemia • Cani P, Bibiloni R, Knauf C, Waget A, Neyrinck A, Delzenne N, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 57:1470–81.10.2337/db07-1403
  • 30. High Fiber diet will increase proportion and function of gut Microbiota
  • 31.
  • 32.
  • 33. Pre/Probiotics as for healthy intestinal microbiota
  • 34.
  • 35.
  • 36. High Fat Diet & Type 2 Diabetes • HFD has also been shown to cause a loss of intestinal T helper (Th) 17 cells putatively through an altered gut microbiota that interfere with the induction of Th17 cells by the antigen-presenting cells, resulting in diminished intestinal defense and integrity • Moreover, it has been demonstrated that immunization with the HFD-associated ileum microbial extracts reversed partially gut microbiota Dysbiosis and prevented hyperglycemia and insulin resistance in response to HFD likely by enhancing the proliferation of intestinal CD4 T cells • This underlines the potential of vaccination for preventing and managing T2DM
  • 37.
  • 38.
  • 39.
  • 40. Conclusion “Dysbiosis of gut Microbiota & obesity with type 2 DM” • As the dysbiosis of gut microbiota is increasingly appreciated as a mechanism accounting for metabolic diseases, the growing understanding of microbiota- driven immune and metabolic responses has begun to reveal potential interventional targets, sustaining the development of new therapeutic strategies by dietary and/or pharmacological means
  • 41. Conclusion “Dysbiosis of gut Microbiota & obesity with type 2 DM” • Dietary intervention (e.g., prebiotics, probiotics, and postbiotics) and fecal microbiota transplantation that tackle microbiota Dysbiosis • Manipulation of the key players in the intestinal integrity and function, bacterial recognition and translocation, tissue inflammation, and host nutrient-sensing mechanisms by using : • recent reports about vaccination and genetic modulation of the gut microbial metabolites further add to our knowledge of the therapeutics of metabolic diseases
  • 42. The “Perfect Storm” for Type 1 Diabetes The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity
  • 43. Dysbiosis of gut Microbiota & type 1 diabetes • Recent data showed the critical role of the gastrointestinal microbiota in the protection or the triggering of type 1 diabetes • In both models, the target pancreatic insulin producing beta cells are attacked and destroyed by activated immune cells, leading to type-1 diabetes. • In human, the incidence of type 1 diabetes has increased during the past several decades in developed countries where environmental conditions have dramatically changed
  • 44. Dysbiosis of gut Microbiota & type 1 diabetes • Increased intestinal permeability has been observed in animal models of type 1 diabetes as well as in humans with or at increased-risk for the disease • An altered mucosal immune system has been associated with the disease and is likely a major contributor resulting in the autoimmunity that underlies type 1 diabetes
  • 45. Dysbiosis of gut Microbiota & type 1 diabetes • This hypothesis suggests that bacterial antigens would be presented by the innate immune system to the T lymphocytes very early in life supporting the notion that immunostimulation can benefit the maturation of the postnatal immune system • Consequently, in case of misrecognition of the bacterial antigen, the adaptive immune system will be exacerbating its aggressiveness against the pancreatic cells and destroy them • Consequently, the recognition of bacterial determinants from intestinal Microbiota would be a triggering factor of autoimmune disease • The Toll-like receptors (TLRs) are innate pattern-recognition receptors involved in host defense that control over commensal bacteria and maintain tissue integrity • The corresponding signaling molecule is MyD88 adaptor, therefore mice lacking this molecular mechanisms were protected against insulitis
  • 46.
  • 47. Hypothetical model of the contribution of various gut components to the pathogenesis of type 1 diabetes. Outi Vaarala et al. Diabetes 2008;57:2555-2562 ©2008 by American Diabetes Association
  • 48. Conclusion • Clearly, much work remains in terms of understanding the role of the gut in type 1 & type 2 diabetes development. • Despite numerous studies showing health benefits of probiotics, the enthusiasm for their application as well as other means to alter the intestinal microbial ecosystem in the prevention of diabetes needs to be tempered due to the current lack of knowledge of the normal developing intestinal microbiota, in addition to questions as to how it affects the developing immune system
  • 49. Conclusion /Future understanding • Future studies using newly developed techniques to evaluate intestinal Microbiota, coupled with the rapidly emerging fields of proteomics and metabolomics, are certainly needed • Finally, the role of gut as modulator of –cell autoimmunity, and/or as the place for initiation of –cell autoimmunity, should provide new understanding of the changing incidence of type 1 diabetes at different times and in different populations